Zaloguj się

Gotowe bibliografie tematyczne / Drugs / Artykuły w czasopismach

Artykuły w czasopismach na temat „Drugs”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Drugs.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 29 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Drugs”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Khanapure, Amol, Pem Chuki i Avinash De Sousa. "Drug Repositioning : Old Drugs For New Indications". Indian Journal of Applied Research 4, nr 8 (1.10.2011): 462–66. http://dx.doi.org/10.15373/2249555x/august2014/119.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Bocharova, Inna Anatolevna, Vadim Agadzhanov i Vadim Sagalaev. "Drug addiction. Drugs and their effects on man". Vestnik Volgogradskogo Gosudarstvennogo Universiteta. Serija 11. Estestvennye nauki, nr 2 (1.12.2013): 22–27. http://dx.doi.org/10.15688/jvolsu11.2013.2.3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Isnenia, Isnenia. "Penggunaan Non-Steroid Antiinflamatory Drug dan Potensi Interaksi Obatnya Pada Pasien Muskuloskeletal". Pharmaceutical Journal of Indonesia 6, nr 1 (1.12.2020): 47–55. http://dx.doi.org/10.21776/ub.pji.2020.006.01.8.

Pełny tekst źródła

Streszczenie:

The main therapy on musculoskeletal patients is the use of non-steroidal anti-inflammatory drugs (NSAIDs) either as monotherapy or in combination with drugs of the same class or pain relievers from other groups. The use of more than one drugs have potentially caused drug-drug interactions that can affect to patient. This study was aimed to describe the patient's sociodemographic (sex, ages) and clinical (numbers of drugs, type of drugs and diagnose) characteristics, as well as to find the correlation between potential drug interactions with these variables. This research was a quantitative study with a cross sectional design. Data were taken from 100 medical records of patients who had diagnosed with top five musculoskeletal diseases. Data were analyzed descriptively for sex, ages, number of drugs, type of drugs, and potential drug interactions. Bivariate correlation with chi-square were conducted to find statistically significancy potential drug interactions with each variable consist of sex, ages, type of drugs and it’s diagnose. The result shows that the musculoskeletal patients were 44% male, 56% female. Most musculoskeletal patients were aged 18-65 years (78%). Patients who received drugs <5 were 68% and ≥ 5 were 32%. 54% of patients were taking the diclofenac and only 5% of patients were taking the two NSAIDs combination, diclofenac and ibuprofen. There was no significant correlation (p > 0,05) between potential drug interactions with age, sex, type of NSAID, and type of musculosceletal diseases.

Style APA, Harvard, Vancouver, ISO itp.

4

Renner, Rebecca. "Drams of Drugs and Dregs". Scientific American 286, nr 5 (maj 2002): 29. http://dx.doi.org/10.1038/scientificamerican0502-29.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Ismatov, Farrukh Asliddinovich. "DRUG TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS JAW ALVEOLITIS". Frontline Medical Sciences and Pharmaceutical Journal 02, nr 03 (1.03.2022): 88–94. http://dx.doi.org/10.37547/medical-fmspj-02-03-09.

Pełny tekst źródła

Streszczenie:

Non-steroidal anti-inflammatory drugs are widely used to suppress inflammation in the body. NSAIDs are available in different forms: tablets, capsules, ointments. They have three main properties: antipyretic, anti-inflammatory and analgesic. The best non-steroidal anti-inflammatory drug can only be chosen by a doctor, based on the individual characteristics of the patient. Self-treatment in this case may be fraught with serious adverse reactions or overdose. We suggest reading the list of drugs. The rating is based on value for money, patient feedback and expert opinion.

Style APA, Harvard, Vancouver, ISO itp.

6

A. Amer, Sayed. "المخدرات الجديدة: العقاقير المصممة". Security Policy Paper 2, nr 2 (31.12.2021): 01–03. http://dx.doi.org/10.26735/ndan7653.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

D, Subba Reddy, Prasanthi G, Amruth Raj S, Hari Krishna T, Sowjanya K i Shantha Kumari K. "EVALUATION OF ANTICANCER GENERIC DRUGS AND BRANDED DRUGS". Indian Research Journal of Pharmacy and Science 5, nr 1 (marzec 2018): 1378–91. http://dx.doi.org/10.21276/irjps.2018.5.1.16.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Khrypunova, Tetiana. "Relationships between the Ukrainian Public's Awareness of Psychotropic Drugs, Stigmatizing People Taking Psychotropic Drugs and Stopping Psychotropic Drug Medication without Consulting with a Doctor". Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, nr 5 (27.10.2021): 370–75. http://dx.doi.org/10.26693/jmbs06.05.370.

Pełny tekst źródła

Streszczenie:

The purpose of the study was to outline possible relationships between public awareness of psychotropic drugs, stigmatization of people suffering from mental disorders and discontinuation of drugs without consultation with a doctor in Ukraine. Materials and methods. This study is based on the analysis of data obtained through an electronic questionnaire filled out by the Ukrainian public. Until April 2021 the questionnaire was freely available to everyone who wanted to take part in the survey. The questionnaire was distributed via an Internet link. Based on the obtained data, the respondents were divided into different categories depending on their education, profession (a medical worker was analyzed separately). Also, the respondents who had personal experience of using psychotropic drugs were interviewed especially deeply and in more details, depending on which group of drugs they used (antidepressants / antipsychotics / anxiolytics). The separate place in the study was given to identifying the general awareness of the Ukrainian public about correct and erroneous judgments about psychotropic drugs. Results and discussion. Based on the obtained data, main factors which are influencing people awareness of psychotropic drugs were identified, as well as the approximate percentage of citizens with erroneous judgments about psychotropic drugs. Thanks to the results of the questionnaire, the main possible reasons for the withdrawal of treatment with psychotropic drugs by patients without consultation with the attending physician were suggested (identified). Conclusion. It can be concluded from the obtained data that a person's awareness in the field of psychotropic drugs is most influenced by their own experience of their use. For this reason, the author would be interested to know how psychiatric patients are informed by their physicians. The author is aware that the amount of data obtained is not completely sufficient to create a significant picture of the general situation, but she hopes that the obtained data will still allow to get some idea of the situation as a whole. In conclusion, not only the obtained results in this study were outlined, but also possible further actions to obtain a more accurate picture of the situation were mentioned, and the topic of the next study was indicated in order to solve the identified problem

Style APA, Harvard, Vancouver, ISO itp.

9

Gillam, Tony. "Drugs or no drugs?" Nursing Standard 20, nr 23 (15.02.2006): 26–27. http://dx.doi.org/10.7748/ns.20.23.26.s30.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Chawra, Himmat Singh, Y. S. Tanwar, Ritu M. Gilhotra i S. K. Singh. "Gastroretentive drug delivery systems a potential approach for antihypertensive drugs: An updated review". Asian Pacific Journal of Health Sciences 5, nr 2 (czerwiec 2018): 217–23. http://dx.doi.org/10.21276/apjhs.2018.5.2.40.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Singh, Uday, Gurjeet Singh i Randhir Singh. "A STUDY ON DRUG UTILIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN TERTIARY CARE HOSPITAL". INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 7, nr 2 (czerwiec 2020): 2184–93. http://dx.doi.org/10.21276/irjps.2020.7.2.11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Kaniwa, Masa-aki. "Drugs, Quasi-drugs and Cosmetics :". Material Cycles and Waste Management Research 25, nr 3 (31.05.2014): 173–79. http://dx.doi.org/10.3985/mcwmr.25.173.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Frey, Bruno S. "Drugs: Drugs, economics and policy". Economic Policy 12, nr 25 (październik 1997): 387–98. http://dx.doi.org/10.1111/1468-0327.00026.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Frey, Bruno S. "Drugs: Drugs, economics and policy". Economic Policy 12, nr 25 (październik 1997): 387–98. http://dx.doi.org/10.1111/1468-0327.t01-1-00025.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Gao, Shan, Anoliefo Ijeoma Janefrancis, Qingwei Cui, Yuqian Mi, Zhou Tong i Bingxue Yan. "RNAi drugs: Next generation drugs?" Chinese Science Bulletin 65, nr 7 (1.03.2020): 540–46. http://dx.doi.org/10.1360/tb-2019-0211.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Andersen, T. "Are newer drugs better drugs?" Obesity Reviews 4, nr 2 (maj 2003): 75. http://dx.doi.org/10.1046/j.1467-789x.2003.00097.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Bateman, D. N., i S. Chaplin. "New Drugs: Centrally acting drugs". BMJ 296, nr 6619 (6.02.1988): 417–19. http://dx.doi.org/10.1136/bmj.296.6619.417.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

., Nurhaedah, Santalia Banne Tondok, Juherah ., M. Ikbal Arif, Sulistyani Prabu Aji, Nurril Cholifatul Izza, Aminuddin . i in. "My Drugs Your Drugs, Indonesia". International Journal of Membrane Science and Technology 10, nr 2 (21.06.2023): 193–96. http://dx.doi.org/10.15379/ijmst.v10i2.1179.

Pełny tekst źródła

Streszczenie:

Social Phenomena of Narcotics Circulation, especially Sidenreng Rappang Regency, has not shown maximum results, and even seems to be increasingly rampant to the remote villages. Sidenreng Rappang Regency, South Sulawesi Province, is known as the Lumbung Beras area, recently this positive stigma has shifted that Sidenreng Rappang Regency is now better known as the Narcotics Granary which is one of the drug trafficking centers in South Sulawesi. The results of the study obtained data, in 2015 with the number of 82 cases with 109 suspects, 2016 with 111 cases with 149 suspects, and 2017 with 140 cases with 197 suspects, and 2018 with 59 cases with the number of suspects 99 (Results of direct interviews with Sidrap Police Narcotics Officers and administrative staff, 31 July 2018). 1.Take strict action in accordance with the applicable law towards producers, distributors and users and carry out effective and educative coordination steps with related parties and the community. 2. Strive to increase the budget to rehabilitate victims of narcotics, psychotropic and other addictive substances.

Style APA, Harvard, Vancouver, ISO itp.

19

PALA, Elif, i Tuba DENKÇEKEN. "Integrating sub-pathway analysis to identify candidate drugs for COVID-19". International Journal of Medical Reviews and Case Reports 4, Reports in Neurology, Neurosur (2020): 71. http://dx.doi.org/10.5455/ijmrcr.covid-19-drugs.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Lee, Rensselaer W. "Drugs". Current History 95, nr 598 (1.02.1996): 55–58. http://dx.doi.org/10.1525/curh.1996.95.598.55.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Jones, Jacquie. "Drugs". Callaloo 13, nr 2 (1990): 299. http://dx.doi.org/10.2307/2931703.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Forrest, Jill. "Drugs . . ." Medical Journal of Australia 159, nr 5 (wrzesień 1993): 352. http://dx.doi.org/10.5694/j.1326-5377.1993.tb137879.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Izenman, Alan Julian. "Drugs". Statistical Science 16, nr 1 (luty 2001): 35–57. http://dx.doi.org/10.1214/ss/998929475.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

&NA;. "DRUGS". Nursing 24, nr 12 (grudzień 1994): 49–56. http://dx.doi.org/10.1097/00152193-199412000-00019.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Rushforth, Bruno. "Drugs". BMJ 328, Suppl S3 (1.03.2004): 0403129. http://dx.doi.org/10.1136/sbmj.0403129.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Spillane, Joseph F. "Drugs". JAMA 289, nr 15 (16.04.2003): 1997. http://dx.doi.org/10.1001/jama.289.15.1997-a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Cerami, A., i K. S. Warren. "Drugs". Parasitology Today 10, nr 10 (styczeń 1994): 404–6. http://dx.doi.org/10.1016/0169-4758(94)90234-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Small, Douglas. "Drugs". Victorian Literature and Culture 51, nr 3 (2023): 391–94. http://dx.doi.org/10.1017/s1060150323000165.

Pełny tekst źródła

Streszczenie:

This “Keywords Redux” article examines the significance of drugs (psychoactive substances) in Victorian culture and literature, theorizing their potential for both performance enhancement and for pleasure.

Style APA, Harvard, Vancouver, ISO itp.

29

Jovicic, Jelena, Branka Gvozdic, Ljubisa Volas, Tatjana Brkic, Natasa Petrovic i Nebojsa Ladjevic. "Old drugs are new again (drugs)". Serbian Journal of Anesthesia and Intensive Therapy 39, nr 5-6 (2017): 159–66. http://dx.doi.org/10.5937/sjait1706159j.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

O'connor, Louise, David Best, Rachel Best i Jenny Rowley. "Missed Opportunities: Drugs and Drugs Education". Early Child Development and Care 141, nr 1 (styczeń 1998): 73–109. http://dx.doi.org/10.1080/0300443981410106.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Prinz, Aloys. "Drugs: Do European drugs policies matter?" Economic Policy 12, nr 25 (październik 1997): 371–85. http://dx.doi.org/10.1111/1468-0327.00025.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Williams, Robert. "Discontinued drugs in 2007: oncology drugs". Expert Opinion on Investigational Drugs 17, nr 12 (3.11.2008): 1791–816. http://dx.doi.org/10.1517/13543780802465737.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Xu-song, Zhang, i Xiang Bing-ren. "Discontinued drugs in 2007: cardiovascular drugs". Expert Opinion on Investigational Drugs 17, nr 12 (3.11.2008): 1817–28. http://dx.doi.org/10.1517/13543780802465992.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Xu-song, Zhang, i Xiang Bing-ren. "Discontinued drugs in 2008: cardiovascular drugs". Expert Opinion on Investigational Drugs 18, nr 7 (24.06.2009): 875–85. http://dx.doi.org/10.1517/13543780903020308.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Williams, Robert. "Discontinued drugs in 2008: oncology drugs". Expert Opinion on Investigational Drugs 18, nr 11 (11.08.2009): 1581–94. http://dx.doi.org/10.1517/13543780903151806.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Suckling, Keith. "Discontinued drugs in 2005: cardiovascular drugs". Expert Opinion on Investigational Drugs 15, nr 11 (16.10.2006): 1299–308. http://dx.doi.org/10.1517/13543784.15.11.1299.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Kelland, Lloyd. "Discontinued drugs in 2005: oncology drugs". Expert Opinion on Investigational Drugs 15, nr 11 (16.10.2006): 1309–18. http://dx.doi.org/10.1517/13543784.15.11.1309.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Kerwin, Robert. "Discontinued drugs in 2005: schizophrenia drugs". Expert Opinion on Investigational Drugs 15, nr 12 (15.11.2006): 1487–95. http://dx.doi.org/10.1517/13543784.15.12.1487.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Williams, Robert. "Discontinued drugs in 2006: oncology drugs". Expert Opinion on Investigational Drugs 17, nr 3 (marzec 2008): 269–83. http://dx.doi.org/10.1517/13543784.17.3.269.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Zhao, Hong-ping, Xu-song Zhang i Bing-ren Xiang. "Discontinued drugs in 2010: cardiovascular drugs". Expert Opinion on Investigational Drugs 20, nr 10 (26.08.2011): 1311–25. http://dx.doi.org/10.1517/13543784.2011.611500.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Williams, Robert. "Discontinued drugs in 2010: oncology drugs". Expert Opinion on Investigational Drugs 20, nr 11 (28.09.2011): 1479–96. http://dx.doi.org/10.1517/13543784.2011.623697.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Chang, Sang G., i Puzant C. Torigian. "Expired Drugs are not Dead Drugs". American Journal of Health-System Pharmacy 50, nr 3 (1.03.1993): 447–48. http://dx.doi.org/10.1093/ajhp/50.3.447.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Zhao, Hong-Ping, Hong-Min Jiang i Bing-Ren Xiang. "Discontinued drugs in 2011: cardiovascular drugs". Expert Opinion on Investigational Drugs 21, nr 10 (25.07.2012): 1449–62. http://dx.doi.org/10.1517/13543784.2012.710198.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Williams, Robert. "Discontinued drugs in 2011: oncology drugs". Expert Opinion on Investigational Drugs 22, nr 1 (6.11.2012): 9–34. http://dx.doi.org/10.1517/13543784.2013.739605.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Zhao, Hong-Ping, Hong-Min Jiang i Bing-Ren Xiang. "Discontinued drugs in 2012: cardiovascular drugs". Expert Opinion on Investigational Drugs 22, nr 11 (30.08.2013): 1437–51. http://dx.doi.org/10.1517/13543784.2013.832198.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Williams, Robert. "Discontinued drugs in 2012: oncology drugs". Expert Opinion on Investigational Drugs 22, nr 12 (8.10.2013): 1627–44. http://dx.doi.org/10.1517/13543784.2013.847088.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Cogen, Jonathan D., David P. Nichols, Christopher H. Goss i Ranjani Somayaji. "Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections". Journal of the Pediatric Infectious Diseases Society 11, Supplement_2 (1.09.2022): S32—S39. http://dx.doi.org/10.1093/jpids/piac061.

Pełny tekst źródła

Streszczenie:

Abstract Airway infections have remained a prominent feature in persons living with cystic fibrosis (CF) despite the dramatic improvements in survival in the past decades. Antimicrobials are a cornerstone of infection management for both acute and chronic maintenance indications. Historic clinical trials of antimicrobials in CF have led to the adoption of consensus guidelines for their use in clinical care. More recently, however, there are efforts to re-think the optimal use of antimicrobials for care with the advent of novel and highly effective CF transmembrane conductance regulator modulator therapies. Encouragingly, however, drug development has remained active concurrently in this space. Our review focuses on the evidence for and perspectives regarding antimicrobial use in both acute and maintenance settings in persons with CF. The therapeutic innovations in CF and how this may affect antimicrobial approaches are also discussed.

Style APA, Harvard, Vancouver, ISO itp.

48

Zaccara, Gaetano, i Emilio Perucca. "Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs". Epileptic Disorders 16, nr 4 (grudzień 2014): 409–31. http://dx.doi.org/10.1684/epd.2014.0714.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Siegel, Miles G., i Michal Vieth. "Drugs in other drugs: a new look at drugs as fragments". Drug Discovery Today 12, nr 1-2 (styczeń 2007): 71–79. http://dx.doi.org/10.1016/j.drudis.2006.11.011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Suresh, Suresh, Pratiti Pratiti, Sunita Sunita, Sona Sona, Soni Soni, Tulika Tulika i Mahalingam Mahalingam. "Over The Counter Drugs". Asian Pacific Journal of Health Sciences 1, nr 4 (październik 2014): 365–69. http://dx.doi.org/10.21276/apjhs.2014.1.4.10.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!